Registered entities
Ventirx Pharmaceuticals, Inc.
Reg. No. 204986639United States
Investor mix
5 investors on record; lead investors include Celgene.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 1 | 20% |
| Other / undisclosed | 1 | 20% |
Developing small molecule product candidates targeting Toll-like receptor 8 (TLR8) for cancer
5 investors on record; lead investors include Celgene.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 1 | 20% |
| Other / undisclosed | 1 | 20% |